In order to investigate the association between the expression level of MIR17HG and the clinicopathological characteristics of breast cancer patients, the TCGA database was utilized to evaluate the link between the expression level of MIR17HG and the survival rate of breast cancer patients. Here, MIR17HG is linked to breast carcinoma.